NASDAQ:BNTX

Biontech Se Sponsored Adr Stock News

etoro logo Buy BNTX
*Your capital is at risk
$90.58
-2.27 (-2.44%)
At Close: Jul 31, 2026
Tumour Vaccine Market analysis report puts across the idea of a high-level analysis of major market segments and identification of opportunities. This information not only aids businesses in taking sound and proficient decisions but also helps decide the advertising, promotion,
Creative Financial Designs Inc. ADV bought a new stake in BioNTech SE (NASDAQ:BNTX) in the third quarter, HoldingsChannel.com reports. The firm bought 100 shares of the companys stock, valued at approximately $27,000. Several other institutional investors have also made changes to their positions in BNTX. Firestone Capital Management bought a new stake in shares of []
The booster dose of Pfizer (PFE) and BioNTechs (BNTX) COVID-19 vaccine has received extended authorization for emergency use from the U.S. The post Pfizer-BioNTechs COVID-19 Booster Gets FDA Approval for People 18 & Above appeared first on Smarter Analyst .

Pfizer shot 100% effective in 12- to 15-year-olds - study

12:07pm, Monday, 22'nd Nov 2021 Breaking the News 24/7
Pfizer Inc. and BioNTech SE announced on Monday the results of the phase 3 trial of their COVID-19 vaccine in adolescents between the ages of 12 and 15. The trial included 2,228 participants and showe
Neoantigen Vaccine Market is an outstanding market research report that conducts industry analysis on products, markets, companies, industries, and many countries worldwide. When it is about guessing general market conditions, the growth prospects in the market, likely restrictions, significant industry
Pfizer-BioNTech vaccine demonstrated 100% efficacy against COVID-19 in longer-term analysis, with no serious safety concerns identified Data will support planned submissions for full regulatory app
NEW YORK and MAINZ, GERMANY, November 22, 2021 Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced topline results from a longer-term analysis of the safety and efficacy of their COVID-19 vaccine in individuals 12 through 15 years of age. The updated findings from the companies pivotal Phase 3 trial show that a two-dose series of the Pfizer-BioNTech COVID-19 Vaccine (30-µg per dose) was 100% effective against COVID-19, measured seven days through over four months after the second dose.
The FDA authorizes booster doses of COVID-19 vaccines of PFE/BNTX and MRNA for use in all adults irrespective of the risk of exposure to coronavirus.
Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) have announced topline results from a longer-term analysis of the safety and efficacy of their COVID-19 Vaccine in individuals 12 through 15
These awesome stocks don't need COVID-19 to beat the market.
Pfizer Inc. PFE, -1.19% and BioNTech SE BNTX, +5.73% said Monday that topline results from a longer-term analysis of the safety and efficacy of their COVID-19 vaccine in people 12 through 15 show that
Two of the main Western producers of COVID-19 vaccines plan to open manufacturing plants in Africa. Moderna is to invest up to USD500m for the construction of a state-of-the-art facility in an unspecified location within two to four years. Over time the plan is to produce 500 million vaccines per year. BioNTech, the German partner []

Pfizer co-developer says Covid vaccination will be annual

10:12pm, Sunday, 21'st Nov 2021 Big News Network
People around the world will need to get a jab against Covid-19 once a year, at least when it comes to the Pfizer vaccine, BioNTech''s CEO Ugur Sahin said in an interview on Sunday, as he praised the quality of its booster shot. In an interview with Germany''s Bild newspaper on Sunday, Sahin said he considers the vaccine, co-developed by his company, to be "very effective." When asked whether

BioNTech boss says youll need to get a Covid jab every year

09:16pm, Sunday, 21'st Nov 2021 Big News Network
People around the world will need to get a jab against Covid-19 once a year, at least when it comes to the Pfizer vaccine, BioNTech''s CEO Ugur Sahin said in an interview on Sunday, as he praised the quality of its booster shot. In an interview with Germany''s Bild newspaper on Sunday, Sahin said he considers the vaccine, co-developed by his company, to be "very effective." When asked whether

Israel to vaccinate children ages 5-11 from Tuesday

08:44pm, Sunday, 21'st Nov 2021 The Bobr Times
MISE & Agrave; DAY Vaccination in Israel of children aged 5 to 11 against COVID-19 with Pfizer/BioNtech doses will begin on Tuesday, Prime Minister Naftali Bennett announced on Friday. & nbsp; Starting Tuesday, children can get vaccinated too, Bennett wrote on his Facebook page, promising full transparency on the subject. According to the trials clinical [] The post Israel to vaccinate children ages 5-11 from Tuesday first appeared on The Bobr Times .
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE